{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:00:39Z","timestamp":1787655639336,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10585-024-10301-6","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T12:01:57Z","timestamp":1721217717000},"page":"667-678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Stereotactic radiotherapy for liver oligometastases: a pooled analysis following the estro\/eortc consensus recommendations"],"prefix":"10.1007","volume":"41","author":[{"given":"D.","family":"Pezzulla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Chiloiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. M.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Macchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Reina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Panza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. G.","family":"Morganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Deodato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"issue":"4","key":"10301_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.rpor.2020.04.021","volume":"25","author":"C de la Pe\u00f1a","year":"2020","unstructured":"de la Pe\u00f1a C, Gonzalez MF, Gonz\u00e1lez C, Salazar JM, Cruz B (2020) Stereotactic body radiation therapy for liver metastases: clinical outcomes and literature review. Rep Pract Oncol Radiother 25(4):637\u2013642. https:\/\/doi.org\/10.1016\/j.rpor.2020.04.021","journal-title":"Rep Pract Oncol Radiother"},{"issue":"12","key":"10301_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/PL00002379","volume":"177","author":"J Wulf","year":"2001","unstructured":"Wulf J, Hadinger U, Oppitz U et al (2001) Stereotactic radiotherapy of targets in thelung and liver. Strahlenther Oncol 177(12):645\u2013655","journal-title":"Strahlenther Oncol"},{"key":"10301_CR3","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1080\/02841860600904821","volume":"45","author":"J Wulf","year":"2006","unstructured":"Wulf J, Guckenberger M, Haedinger U et al (2006) Stereotactic radiotherapy of pri-mary liver cancer and hepatic metastases. Acta Oncol 45:838\u2013847","journal-title":"Acta Oncol"},{"issue":"3","key":"10301_CR4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.ijrobp.2006.10.025","volume":"67","author":"AW Katz","year":"2007","unstructured":"Katz AW, Carey-Sampson M, Muhs AG, Milano MT, Schell MC, Okunieff P (2007) Hypofractionated stereotactic body radiation therapy (SBRT) for limited hep-atic metastases. Int J Radiat Oncol Biol Phys 67(3):793\u2013798","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10301_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.radonc.2022.01.019","volume":"168","author":"J Willmann","year":"2022","unstructured":"Willmann J, Vlaskou Badra E, Adilovic S, Ahmadsei M, Christ SM, van Timmeren JE, Kroeze SGC, Mayinger M, Guckenberger M, Andratschke N (2022) Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: a retrospective single center study. Radiother Oncol 168:256\u2013264. https:\/\/doi.org\/10.1016\/j.radonc.2022.01.019","journal-title":"Radiother Oncol"},{"key":"10301_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13:8\u201310","journal-title":"J Clin Oncol"},{"key":"10301_CR7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nrclinonc.2014.96","volume":"11","author":"DA Palma","year":"2014","unstructured":"Palma DA, Salama JK, Lo SS, Senan S, Treasure T, Govindan R et al (2014) The oligometastatic state\u2014separating truth from wishful thinking. Nat Rev Clin Oncol 11:549\u2013557","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10301_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/00000658-200206000-00002","volume":"235","author":"MA Choti","year":"2002","unstructured":"Choti MA, Sitzman JV, Tiburi MF et al (2002) Trends in long-term survivalfollowing liver resection for hepatic colorectal metastases. Ann Surg 235(6):759\u2013766","journal-title":"Ann Surg"},{"issue":"29","key":"10301_CR9","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1200\/JCO.2007.11.0833","volume":"25","author":"JS Tomlinson","year":"2007","unstructured":"Tomlinson JS, Jarnagin WR, DeMatteo RP, Fog Y et al (2007) Actual 10-year sur-vival after resection of colorectal liver metastases defines cure. J Clin Oncol 25(29):4575\u20134580","journal-title":"J Clin Oncol"},{"issue":"10","key":"10301_CR10","first-page":"742","volume":"9","author":"R Small","year":"2007","unstructured":"Small R, Lubezky N, Ben-Haim M (2007) Current controversies in the surgicalmanagement of colorectal cancer metastases to the liver. Isr Med Assoc J 9(10):742\u2013747","journal-title":"Isr Med Assoc J"},{"issue":"4","key":"10301_CR11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.amjsurg.2007.06.024","volume":"195","author":"S Garrean","year":"2008","unstructured":"Garrean S, Hering J, Saied A, Helton WS, Espat NJ (2008) Radiofrequency ablation ofprimary and metastatic liver tumors: a critical review of the literature. Am J Surg 195(4):508\u2013520","journal-title":"Am J Surg"},{"issue":"1","key":"10301_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1148\/radiol.2211001624","volume":"221","author":"L Solbaiti","year":"2001","unstructured":"Solbaiti L, Livraghi T, Golberg SN et al (2001) Percutaneous radiofrequency ablation ofhepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221(1):159\u2013166","journal-title":"Radiology"},{"issue":"6","key":"10301_CR13","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1097\/SLA.0000000000000234","volume":"259","author":"RT Groeschl","year":"2014","unstructured":"Groeschl RT, Pilgrim CH, Hanna EM et al (2014) Microwave ablation for hepatic malig-nancies: a multinstitutional analysis. Ann Surg 259(6):1195\u20131200","journal-title":"Ann Surg"},{"issue":"4","key":"10301_CR14","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00330-006-0372-5","volume":"17","author":"TJ Volg","year":"2007","unstructured":"Volg TJ, Zangos S, Eichler K, Yakaoub D, Nabil M (2007) Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hep-atic chemoperfusion: an update. Eur Radiol 17(4):1025\u20131034","journal-title":"Eur Radiol"},{"issue":"2","key":"10301_CR15","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijrobp.2012.12.021","volume":"86","author":"M Scorsetti","year":"2013","unstructured":"Scorsetti M, Arcangeli S, Tozzi A, Comito T, Alongi F, Navarria P, Mancosu P, Reggiori G, Fogliata A, Torzilli G, Tomatis S, Cozzi L (2013) Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial. Int J Radiat Oncol Biol Phys 86(2):336\u2013342. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.12.021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10301_CR16","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","volume":"53","author":"LA Dawson","year":"2002","unstructured":"Dawson LA, Normolle D, Balter JM et al (2002) Analysis of radiationinduced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53:810\u2013821","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10301_CR17","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1200\/JCO.2006.09.7469","volume":"25","author":"RD Timmerman","year":"2007","unstructured":"Timmerman RD, Kavanagh BD, Cho LC et al (2007) Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 25:947\u2013952","journal-title":"J Clin Oncol"},{"key":"10301_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.radonc.2019.12.004","volume":"145","author":"J Lee","year":"2020","unstructured":"Lee J, Shin IS, Yoon WS, Koom WS, Rim CH (2020) Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: meta-analyses and a systematic review. Radiother Oncol 145:63\u201370. https:\/\/doi.org\/10.1016\/j.radonc.2019.12.004","journal-title":"Radiother Oncol"},{"issue":"1","key":"10301_CR19","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","volume":"21","author":"M Guckenberger","year":"2020","unstructured":"Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM, Dingemans AC, Fournier B, Hurkmans C, Lecouvet FE, Meattini I, M\u00e9ndez Romero A, Ricardi U, Russell NS, Schanne DH, Scorsetti M, Tombal B, Verellen D, Verfaillie C, Ost P (2020) Characterisation and classification of oligometastatic disease: a European society for radiotherapy and oncology and European organisation for research and treatment of cancer consensus recommendation. Lancet Oncol 21(1):e18\u2013e28. https:\/\/doi.org\/10.1016\/S1470-2045(19)30718-1","journal-title":"Lancet Oncol"},{"key":"10301_CR20","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341\u20131346","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10301_CR21","unstructured":"National Cancer Institute Common Terminology Criteria for Adverse Events v.4.03 (CTCAEv.4.03)"},{"key":"10301_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz LH, Liti\u00e8re S, de Vries E et al (2016) RECIST 1.1-update and clarification: from the RECIST committee. Eur J Cancer 62:132\u2013137. https:\/\/doi.org\/10.1016\/j.ejca.2016.03.081","journal-title":"Eur J Cancer"},{"issue":"5","key":"10301_CR23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.clon.2022.02.010","volume":"34","author":"P Diez","year":"2022","unstructured":"Diez P, Hanna GG, Aitken KL, van As N, Carver A, Colaco RJ, Conibear J, Dunne EM, Eaton DJ, Franks KN, Good JS, Harrow S, Hatfield P, Hawkins MA, Jain S, McDonald F, Patel R, Rackley T, Sanghera P, Tree A, Murray L (2022) UK 2022 consensus on normal tissue dose-volume constraints for oligometastatic, primary lung and hepatocellular carcinoma stereotactic ablative radiotherapy. Clin Oncol (R Coll Radiol) 34(5):288\u2013300. https:\/\/doi.org\/10.1016\/j.clon.2022.02.010","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"10301_CR24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/bjs.6895","volume":"97","author":"AE van der Pool","year":"2010","unstructured":"van der Pool AE, M\u00e9ndez Romero A, Wunderink W et al (2010) Stereotactic body radiation therapy for colorectal liver metastases. Br J Surg 97(3):377\u2013382. https:\/\/doi.org\/10.1002\/bjs.6895","journal-title":"Br J Surg"},{"issue":"7","key":"10301_CR25","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1080\/02841860600897934","volume":"45","author":"A M\u00e9ndez Romero","year":"2006","unstructured":"M\u00e9ndez Romero A, Wunderink W, Hussain SM et al (2006) Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase i\u2013ii study. Acta Oncol 45(7):831\u2013837. https:\/\/doi.org\/10.1080\/02841860600897934","journal-title":"Acta Oncol"},{"issue":"10","key":"10301_CR26","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","volume":"27","author":"KE Rusthoven","year":"2009","unstructured":"Rusthoven KE, Kavanagh BD, Cardenes H et al (2009) multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27(10):1572\u20131578. https:\/\/doi.org\/10.1200\/JCO.2008.19.6329","journal-title":"J Clin Oncol"},{"issue":"4","key":"10301_CR27","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.ijrobp.2017.12.014","volume":"100","author":"WC Jackson","year":"2018","unstructured":"Jackson WC, Tao Y, Mendiratta-Lala M et al (2018) Comparison of stereotactic body radiation therapy and radiofrequency ablation in the treatment of intrahepatic metastases. Int J Radiat Oncol Biol Phys 100(4):950\u2013958. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.12.014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10301_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.radonc.2018.06.035","volume":"129","author":"F Petrelli","year":"2018","unstructured":"Petrelli F, Comito T, Barni S et al (2018) Stereotactic body radiotherapy for colorectal cancer liver metastases: a systematic review. Radiother Oncol 129(3):427\u2013434. https:\/\/doi.org\/10.1016\/j.radonc.2018.06.035","journal-title":"Radiother Oncol"},{"key":"10301_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fonc.2012.00023","volume":"2","author":"R Lanciano","year":"2012","unstructured":"Lanciano R, Lamond J, Yang J et al (2012) Stereotactic body radiation therapy for patients with heavily pretreated liver metastases and liver tumors. Front Oncol 2:23. https:\/\/doi.org\/10.3389\/fonc.2012.00023","journal-title":"Front Oncol"},{"issue":"10","key":"10301_CR30","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1200\/JCO.2008.20.0600","volume":"27","author":"MT Lee","year":"2009","unstructured":"Lee MT, Kim JJ, Dinniwell R et al (2009) Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 27(10):1585\u20131591. https:\/\/doi.org\/10.1200\/JCO.2008.20.0600","journal-title":"J Clin Oncol"},{"issue":"4","key":"10301_CR31","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1245\/s10434-010-1405-5","volume":"18","author":"W Rule","year":"2011","unstructured":"Rule W, Timmerman R, Tong L et al (2011) Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases. Ann Surg Oncol 18(4):1081\u20131087. https:\/\/doi.org\/10.1245\/s10434-010-1405-5","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10301_CR32","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.ejca.2010.01.008","volume":"46","author":"S Stintzing","year":"2010","unstructured":"Stintzing S, Hoffmann RT, Heinemann V, Kufeld M, Muacevic A (2010) Frameless single-session robotic radiosurgery of liver metastases in colorectal cancer patients. Eur J Cancer 46(6):1026\u20131032. https:\/\/doi.org\/10.1016\/j.ejca.2010.01.008","journal-title":"Eur J Cancer"},{"key":"10301_CR33","doi-asserted-by":"publisher","first-page":"1095633","DOI":"10.3389\/fonc.2022.1095633","volume":"12","author":"L Uder","year":"2023","unstructured":"Uder L, Nachbar M, Butzer S, Boldt J, Baumeister S, Bitzer M, K\u00f6nigsrainer A, Seufferlein T, Hoffmann R, Gatidis S, Nikolaou K, Zips D, Thorwarth D, Gani C, Boeke S (2023) Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastases. Front Oncol 12:1095633. https:\/\/doi.org\/10.3389\/fonc.2022.1095633","journal-title":"Front Oncol"},{"issue":"1","key":"10301_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3857\/roj.2020.00976","volume":"39","author":"G Ugurluer","year":"2021","unstructured":"Ugurluer G, Mustafayev TZ, Gungor G et al (2021) Stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of liver metastases in oligometastatic patients: initial clinical experience. Radiat Oncol J 39(1):33\u201340. https:\/\/doi.org\/10.3857\/roj.2020.00976","journal-title":"Radiat Oncol J"},{"issue":"3","key":"10301_CR35","doi-asserted-by":"publisher","first-page":"850","DOI":"10.4143\/crt.2021.674","volume":"54","author":"J Yu","year":"2022","unstructured":"Yu J, Kim DH, Lee J et al (2022) Radiofrequency ablation versus stereotactic body radiation therapy in the treatment of colorectal cancer liver metastases. Cancer Res Treat 54(3):850\u2013859. https:\/\/doi.org\/10.4143\/crt.2021.674","journal-title":"Cancer Res Treat"},{"issue":"2","key":"10301_CR36","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1634\/theoncologist.2019-0309","volume":"25","author":"G Macchia","year":"2020","unstructured":"Macchia G, Lazzari R, Colombo N et al (2020) A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 Study): a collaboration of MITO, AIRO GYN, and MaNGO groups. Oncologist 25(2):e311\u2013e320","journal-title":"Oncologist"},{"issue":"6","key":"10301_CR37","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1136\/ijgc-2021-003237","volume":"32","author":"G Macchia","year":"2022","unstructured":"Macchia G, Nardangeli A, Laliscia C et al (2022) Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2\/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups. Int J Gynecol Cancer 32(6):732\u2013739","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10301_CR38","first-page":"1","volume":"32","author":"G Macchia","year":"2023","unstructured":"Macchia G, Pezzulla D, Campitelli M et al (2023) Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic uterine cancer (MITO-RT2\/RAD study): a large, real-world study in collaboration with AIRO GYN, MITO and MANGO groups. Int J Radiat Oncol Biol Phys 32(7):1","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10301_CR39","doi-asserted-by":"publisher","first-page":"110072","DOI":"10.1016\/j.radonc.2023.110072","volume":"191","author":"S Cilla","year":"2023","unstructured":"Cilla S, Campitelli M, Antonietta Gambacorta M, Michela Rinaldi R, Deodato F, Pezzulla D, Romano C, Fodor A, Laliscia C, Trippa F, De Sanctis V, Ippolito E, Ferioli M, Titone F, Russo D, Balcet V, Vicenzi L, Di Cataldo V, Raguso A, Giuseppe Morganti A, Ferrandina G, Macchia G (2023) Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer: a multi-institutional study. Radiother Oncol 191:110072. https:\/\/doi.org\/10.1016\/j.radonc.2023.110072","journal-title":"Radiother Oncol"},{"issue":"1","key":"10301_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12885-019-5362-5","volume":"19","author":"RJ Klement","year":"2019","unstructured":"Klement RJ, Abbasi-Senger N, Adebahr S et al (2019) The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases. BMC Cancer 19(1):173. https:\/\/doi.org\/10.1186\/s12885-019-5362-5","journal-title":"BMC Cancer"},{"key":"10301_CR41","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ctrv.2015.03.011","volume":"41","author":"K Reynders","year":"2015","unstructured":"Reynders K, Illidge T, Siva S et al (2015) The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant. Cancer Treat Rev 41:503\u2013510","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"10301_CR42","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.ijrobp.2017.07.030","volume":"99","author":"JH Joo","year":"2017","unstructured":"Joo JH, Park J-H, Kim JC, Chang Sik Y, Lim S-B, Park IJ, Kim TW, Hong YS, Kim K-P, Yoon SM, Park J, Kim JH (2017) Local control outcomes using stereotactic body radiation therapy for liver metastases from colorectal cancer. Int J Radiat Oncol Biol Phys 99(4):876\u2013883. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.07.030","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"10301_CR43","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1002\/cncr.25997","volume":"117","author":"DT Chang","year":"2011","unstructured":"Chang DT, Swaminath A, Kozak M et al (2011) Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer 117(17):4060\u20134069. https:\/\/doi.org\/10.1002\/cncr.25997","journal-title":"Cancer"},{"issue":"7","key":"10301_CR44","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.clon.2015.03.006","volume":"27","author":"K Aitken","year":"2015","unstructured":"Aitken K, Tree A, Thomas K et al (2015) Initial UK experience of stereotactic body radiotherapy for extracranial oligometastases: can we change the therapeutic paradigm? Clin Oncol (R Coll Radiol) 27(7):411\u2013419. https:\/\/doi.org\/10.1016\/j.clon.2015.03.006","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"5","key":"10301_CR45","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.ijrobp.2020.12.012","volume":"109","author":"MR Folkert","year":"2021","unstructured":"Folkert MR, Meyer JJ, Aguilera TA et al (2021) Long-term results of a phase 1 dose-escalation trial and subsequent institutional experience of single-fraction stereotactic ablative radiation therapy for liver metastases. Int J Radiat Oncol Biol Phys 109(5):1387\u20131395. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.12.012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10301_CR46","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ijrobp.2009.08.020","volume":"78","author":"KA Goodman","year":"2010","unstructured":"Goodman KA, Wiegner EA, Maturen KE et al (2010) Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys 78(2):486\u2013493. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.08.020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10301_CR47","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1080\/02841860600904854Rusthoven","volume":"45","author":"M Hoyer","year":"2006","unstructured":"Hoyer M, Roed H, Traberg Hansen A et al (2006) Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 45(7):823\u2013830. https:\/\/doi.org\/10.1080\/02841860600904854Rusthoven","journal-title":"Acta Oncol"},{"issue":"9","key":"10301_CR48","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s00432-020-03223-9","volume":"146","author":"L Nicosia","year":"2020","unstructured":"Nicosia L, Cuccia F, Mazzola R, Figlia V, Giaj-Levra N, Ricchetti F, Rigo M, Bon\u00f9 M, Corradini S, Tolia M, Alongi F (2020) Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases. J Cancer Res Clin Oncol 146(9):2351\u20132358. https:\/\/doi.org\/10.1007\/s00432-020-03223-9","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"10301_CR49","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.ijrobp.2022.08.026","volume":"114","author":"S Baker","year":"2022","unstructured":"Baker S, Mou B, Jiang W, Liu M, Bergman AM, Schellenberg D, Alexander AS, Carolan H, Atrchian S, Berrang T, Bang A, Chng N, Matthews Q, Tyldesley S, Olson RA (2022) Validation of the prognostic utility of ESTRO\/EORTC oligometastatic disease classification: a secondary analysis from the population-based phase II SABR-5 trial. Int J Radiat Oncol Biol Phys 114(5):849\u2013855. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.08.026","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-024-10301-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-024-10301-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-024-10301-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T04:45:42Z","timestamp":1729745142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-024-10301-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10301"],"URL":"https:\/\/doi.org\/10.1007\/s10585-024-10301-6","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]},"assertion":[{"value":"4 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not disclosed any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}